The RhythmView™ Workstation is a computerized system that assists in the diagnosis of complex cardiac arrhythmias. The RhythmView™ Workstation is used to analyze electrogram and electrocardiogram signals and display them in a visual format.
Device Story
RhythmView Workstation is a programmable diagnostic computer used to assist in the diagnosis of complex cardiac arrhythmias. The system takes electrical signals collected from multi-polar electrophysiology catheters as input. It processes these electrogram and electrocardiogram signals to produce a visual output, including a propagation map and a grid display of electrode signals. The device is intended for use by clinicians in a clinical setting. By providing a visual representation of cardiac electrical activity, the system aids healthcare providers in identifying and diagnosing arrhythmias, potentially improving clinical decision-making and patient outcomes.
Clinical Evidence
Bench testing only. The system underwent extensive verification and validation testing using a wide variety of cardiac electrogram data to confirm performance against predetermined specifications. No clinical study data was provided.
Technological Characteristics
Programmable diagnostic computer consisting of a computer, monitor, keyboard, and mouse. Features include signal processing, post-processing propagation map display, and grid display of electrode signals. Does not perform signal capture or location tracking. Software-based analysis of electrogram and electrocardiogram signals.
Indications for Use
Indicated for use as a computerized system to assist in the diagnosis of complex cardiac arrhythmias by analyzing and displaying electrogram and electrocardiogram signals.
Regulatory Classification
Identification
A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.
{0}------------------------------------------------
pg 1 of 2
# Appendix 4 — 510(k) Summary
# 510(k) Summary of Safety and Effectiveness
SEP 2 3 2011
| Submitter's<br>information | Topera, Inc.<br>Contact: Ruchir Sehra, MD<br>Phone: 858 367-3395<br>03/22/2011 |
|-----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Device/<br>classification<br>name | Device Name:<br>• RhythmView Workstation<br><br>Classification/Common name:<br>• Programmable diagnostic computer<br><br>The marketed device(s) to which substantial equivalence is claimed:<br>• Astronomer + (K003362)<br>• CARTO XP Mapping System (K013083) |
| Device<br>description | The RhythmView is comprised of these major components,<br><br>1. RhythmView hardware – Computer, monitor, keyboard, and mouse<br>2. RhythmView Software – Software pre-installed<br><br>The RhythmView Workstation takes electrical signals collected from multi-<br>polar electrophysiology catheters and outputs a graphic display that assists in<br>the diagnosis of cardiac arrhythmias. |
| Indications for<br>use | The RhythmView™ Workstation is a computerized system that assists in the<br>diagnosis of complex cardiac arrhythmias. The RhythmView™ Workstation<br>is used to analyze electrogram and electrocardiogram signals and display<br>them in a visual format. |
| | Continued on next page |
{1}------------------------------------------------
## 510(k) Summary of Safety and Effectiveness, Continued
Technological The table below lists the technological characteristics for both the new and characteristics predicate devices
| Device Characteristic | New Device<br>Rhythm ViewTM | Predicate Device<br>Astronomer + | Predicate Device<br>CARTO XP |
|----------------------------------------------|-----------------------------|----------------------------------|------------------------------|
| Signal capture | No | Yes | Yes |
| Signal processing | Yes | Yes | Yes |
| Location capability | No | Yes | Yes |
| Post processing display -<br>propagation map | Yes | No | Yes |
| Grid display of electrode<br>signals | Yes | Yes | No |
### Performance The RhythmView System underwent extensive bench testing, including a data wide variety of cardiac electrogram data, to demonstrate that it was as safe and as effective as the predicate devices.
The Rhythm View System passed all verification and validation tests in accordance with predetermined specifications and appropriate test criteria. There were no new questions of safety and effectiveness raised.
### Conclusion Verification and validation testing were conducted to establish the performance characteristics of the RhythmView System. The results demonstrate that the Rhythm View is safe and effective when used in accordance with its intended use and labeling.
K110878
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services (HHS). The logo features a stylized caduceus, which is a symbol often associated with healthcare. The caduceus is depicted with three lines forming a shape resembling a bird or abstract human figure. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the caduceus.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WC066-G609 Silver Spring, MD 20993-0002
Topera, Inc. c/o Dr. Ruchir Schra 11445 E. Via Linda Suite 2 P.O. Box 224 Scousdale. AZ 85259
SEP 2 3 201
Re: K110878
Trade/Device Name: RhythmView Regulation Number: 21 CFR 870.1425 Regulation Name: Programmable Diagnostic Computer Regulatory Class: Class II Product Code: DQK Dated: September 8, 2011 Received: September 12, 2011
Dear Dr. Sehra:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interestate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendonants, or 10 devices that have been reclassified in accordance with the provisions of the Federal Food, youg, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbaranding and adulteration. Please note: CDRH does not evaluate information related to contractly antity warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be
{3}------------------------------------------------
Page 2 - Dr. Ruchir Schra
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register,
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050,
If you desire specific advice for your device on our labeling regulation (21 CFR Pari 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
uckerman, M.D. Bram D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
## Appendix 3 - Indications for Use
### Indications for Use Statement
Statement The Indications for Use Statement:
510(k) Number: K110878
Device Name: RhythmView Workstation
The RhythmView™ Workstation is a computerized system that assists in the diagnosis of complex cardiac arrhythmias. The RhythmView™M Workstation is used to analyze electrogram and electrocardiogram signals and display them in a visual format.
Prescription Use X -AND/OR (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (Part 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Page of | |
|------------------------------------|---------|
| (Division Sign-Off) | |
| Division of Cardiovascular Devices | |
| 510(k) Number | K110878 |
Topera, Inc.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.
Sort by:
Create Alert
Search Filters
Agent Token
Create a read-only bearer token for Claude, ChatGPT, or other agents that can call HTTP APIs.